Generics Dispute EU-India Trade Negotiations - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Generics Dispute EU-India Trade Negotiations
The recent India–EU summit was expected to bring news about the upcoming Free Trade Agreement between the EU and India; however, a dispute regarding the supply of generic drugs from India to developing countries has taken centre stage.

Pharmaceutical Technology Europe
Volume 23, Issue 2


1. European Commission, "Bilateral Relations: India" (2010).

2. Securing Pharma, "EU aims to appease India with softened customs law" (2010).

3. Business Standard, "India, EU expect FTA by spring of 2011" (2010).

4. Indian Drug Manufacturers' Association (2010).

5. Médecins Sans Frontières, "At EU-India Summit, European Negotiators Urged Not to Block Access to Affordable Medicines" (2010).

6. AIDS News, "India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries" (2004).

7. Henry J. Kaiser Family Foundation, "India's Trade Minister Says EU Will To Take Steps To Prevent Seizure Of Generic Medicines" (2010).

8. DNA India, "Netherlands assures India to sort out drug seizure issue" (2009).

9. EU Business, "Brazil, India take EU to WTO over generic drug seizures" (2010).

10. The Economic Times, "Indian generics to be safe from seizure while passing through EU" (2010).

11. HM Revenue & Customs, "European Community (EC) legislation. HMRC Reference: Notice 34" (2010).

12. Indian Express, "Indian pharma cos shun EU, route goods via SA ports" (2010).

13. BBC News, "India-EU generic drug row 'resolved' at Brussels summit" (2010).

14. Europe! Hands off our medicine. http://

15. The Guardian, "ANC urged to deliver Aids drugs" (2010).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology Europe,
Click here